Procinolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SLJ0HIL21J. European Medicines Agency schedules Procinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10060MIG. Procinolol generally arises in the molecular formula C15H23NO2. The term PROCINOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , no. 10 1971, list 11.) PROCINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule procinolol under HS 29221980 and SITC 51461. As of Q4 2014, PROCINOLOL remains the US FDA Preferred Term for this commodity. Procinolol bears US NLM identifiers UMLS ID C0072038 and NCI Concept Code C66471. SMILES: O(C1C(C2CC2)CCCC1)CC(O)CNC(C)C.